Efficacy of low-dose methotrexate in rheumatoid arthritis.
暂无分享,去创建一个
M. Weinblatt | D. Glass | J. Coblyn | D. Fox | P. Fraser | D. Trentham | D. Holdsworth
[1] E. Reinherz,et al. Ta1, a novel 105 KD human T cell activation antigen defined by a monoclonal antibody. , 1984, Journal of Immunology.
[2] S. Wahl,et al. Immune function in severe, active rheumatoid arthritis: a relationship between peripheral blood mononuclear cell proliferation to soluble antigens and mononuclear cell subset profiles. , 1984, Journal of immunology.
[3] L. Chylack,et al. Inherited predisposition to iridocyclitis with juvenile rheumatoid arthritis: selectivity among HLA-DR5 haplotypes. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[4] J. Belli,et al. Total lymphoid irradiation therapy in refractory rheumatoid arthritis. Fifteen- to forty-month followup. , 1984, Arthritis and rheumatism.
[5] E. Reinherz,et al. An alternative pathway of T-cell activation: A functional role for the 50 kd T11 sheep erythrocyte receptor protein , 1984, Cell.
[6] M. Corbett,et al. Association of HLA-DR4/Dw4 and DR2/Dw2 with radiologic changes in a prospective study of patients with rheumatoid arthritis. Preferential relationship with HLA-Dw rather than HLA-DR specificities. , 1984, Arthritis and rheumatism.
[7] M. Guttadauria,et al. Comparison of auranofin, gold sodium thiomalate, and placebo in the treatment of rheumatoid arthritis. A controlled clinical trial. , 1983, Arthritis and rheumatism.
[8] D. Clegg,et al. Acute lung disease associated with low-dose pulse methotrexate therapy in patients with rheumatoid arthritis. , 1983, Arthritis and rheumatism.
[9] S. Wahl,et al. Leukapheresis in rheumatoid arthritis. Association of clinical improvement with reversal of anergy. , 1983, Arthritis and rheumatism.
[10] M. Guttadauria,et al. Low-dose D-penicillamine therapy in rheumatoid arthritis. A controlled, double-blind clinical trial. , 1983, Arthritis and rheumatism.
[11] K. Steinsson,et al. Low dose methotrexate in rheumatoid arthritis. , 1982, The Journal of rheumatology.
[12] H. Maibach,et al. Methotrexate guidelines--revised. , 1982, Journal of the American Academy of Dermatology.
[13] D. Mitchell,et al. Preliminary criteria for clinical remission in rheumatoid arthritis. , 1981, Arthritis and rheumatism.
[14] J. Belli,et al. Clinical and immunologic effects of fractionated total lymphoid irradiation in refractory rheumatoid arthritis. , 1981, The New England journal of medicine.
[15] L. Nadler,et al. Antigens on human monocytes identified by monoclonal antibodies. , 1981, Journal of immunology.
[16] L. Nadler,et al. Monoclonal antibodies defining serologically distinct HLA-D/DR related Ia-like antigens in man. , 1981, Human immunology.
[17] L. Nadler,et al. Characterization of a human B lymphocyte-specific antigen. , 1980, Journal of immunology.
[18] Willkens Rf,et al. Low dose pulse methotrexate therapy in rheumatoid arthritis. , 1980 .
[19] G. Panayi,et al. Genetic basis of rheumatoid disease: HLA antigens, disease manifestations, and toxic reactions to drugs. , 1978, British medical journal.
[20] C. Putman,et al. METHOTREXATE-INDUCED PNEUMONITIS , 1976, Medicine.
[21] H. Roenigk,et al. Hepatotoxicity of methotrexate in the treatment of psoriasis. , 1971, Archives of dermatology.
[22] G. W. Snedecor. STATISTICAL METHODS , 1967 .
[23] R. Gubner,et al. THERAPEUTIC SUPPRESSION OF TISSUE REACTIVITY: II. Effect of Aminopterin in Rheumatoid Arthritis and Psoriasis , 1951, The American journal of the medical sciences.
[24] O. Steinbrocker,et al. Therapeutic criteria in rheumatoid arthritis. , 1949, Journal of the American Medical Association.